The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Abbvie Limited .

Filed returns
59
match these filters
Matching filed returns per period 0 2 5 7 10 Sep–Dec 2015: 1 filed returns May–Aug 2016: 1 filed returns Sep–Dec 2016: 1 filed returns Jan–Apr 2017: 2 filed returns May–Aug 2017: 1 filed returns Sep–Dec 2017: 1 filed returns Jan–Apr 2018: 2 filed returns May–Aug 2018: 3 filed returns Jan–Apr 2019: 5 filed returns May–Aug 2019: 7 filed returns Sep–Dec 2019: 9 filed returns Jan–Apr 2020: 1 filed returns May–Aug 2020: 2 filed returns Sep–Dec 2020: 1 filed returns Jan–Apr 2021: 1 filed returns May–Aug 2021: 1 filed returns Sep–Dec 2021: 2 filed returns May–Aug 2022: 1 filed returns Jan–Apr 2023: 1 filed returns May–Aug 2023: 2 filed returns Sep–Dec 2023: 2 filed returns Jan–Apr 2024: 1 filed returns May–Aug 2024: 1 filed returns Sep–Dec 2024: 1 filed returns Jan–Apr 2025: 1 filed returns May–Aug 2025: 1 filed returns Sep–Dec 2025: 1 filed returns Jan–Apr 2026: 1 filed returns May–Aug 2026: 5 filed returns 2017 2018 2019 2020 2021 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
May–Aug 2026 Abbvie Limited Taxation Engagement with Government regarding the business environment in Ireland (Public policy or programme) 1 On lobbying.ie
May–Aug 2026 Abbvie Limited Health Framework Agreement on the Pricing and Supply of medicines (Public policy or programme) 1 On lobbying.ie
May–Aug 2026 Abbvie Limited Economic Development and Industry Competitiveness of Europe and Ireland in relation to Life sciences (Public policy or programme) 1 On lobbying.ie
May–Aug 2026 Abbvie Limited Economic Development and Industry Competitiveness of Europe and Ireland in relation to Life sciences (Public policy or programme) 3 On lobbying.ie
May–Aug 2026 Abbvie Limited Health Competitiveness of Europe and Ireland in relation to Life sciences (Legislation) 2 On lobbying.ie
Jan–Apr 2026 Abbvie Limited Health Competitiveness of Europe and Ireland in relation to Life sciences (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2025 Abbvie Limited Health A letter to the Minister for Health regarding the EU General Pharmaceutical Legislation (GPL) (Legislation) 1 On lobbying.ie
May–Aug 2025 Abbvie Limited Environment Urban Waste water treatment Directive (Legislation) 1 On lobbying.ie
Jan–Apr 2025 Abbvie Limited Economic Development and Industry Competitiveness of Europe and Ireland in relation to Life sciences (Public policy or programme) 3 On lobbying.ie
Sep–Dec 2024 Abbvie Limited Energy and Natural Resources Discussion with the Minister of state on quality of energy supply in Ireland (Public policy or programme) 1 On lobbying.ie
May–Aug 2024 Abbvie Limited Health Meeting with officials from the Department of Health as part of a delegation from the US Chamber of Commerce, to discuss industry wide concerns in Ireland regarding the EU Commission’s proposals to revise the general… (Legislation) 1 On lobbying.ie
Jan–Apr 2024 Abbvie Limited Health EU Pharmaceutical Strategy (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2023 Abbvie Limited Health EU Pharmaceutical Strategy and Access to Medicines (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2023 Abbvie Limited Health Access to Medicines (Matters involving public funds) 2 On lobbying.ie
May–Aug 2023 Abbvie Limited Health EU Pharmaceutical Strategy and Access to Medicines (Public policy or programme) 1 On lobbying.ie
May–Aug 2023 Abbvie Limited EU Affairs EU Pharmaceutical Strategy (Legislation) 1 On lobbying.ie
Jan–Apr 2023 Abbvie Limited Health Dermatology waiting lists (Public policy or programme) 2 On lobbying.ie
May–Aug 2022 Abbvie Limited Health The need to speed up access to innovative medicines in Ireland, particularly in areas with high unmet need (Legislation) 9 On lobbying.ie
Sep–Dec 2021 Abbvie Limited Health Access to medicines in Ireland (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2021 Abbvie Limited Health CSR activities - (corporate social responsibilities) (Public policy or programme) 6 On lobbying.ie
May–Aug 2021 Abbvie Limited Health Access and reimbursement to medicines (Public policy or programme) 3 On lobbying.ie
Jan–Apr 2021 Abbvie Limited Health Health Policy Engagement - Plant Closure (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2020 Abbvie Limited Health Health Policy engagements (Public policy or programme) 11 On lobbying.ie
May–Aug 2020 Abbvie Limited Health World Hepatitis Day 2020 (Public policy or programme) 4 On lobbying.ie
May–Aug 2020 Abbvie Limited Health Discussion about access to medicines (Public policy or programme) 4 On lobbying.ie
Jan–Apr 2020 Abbvie Limited Health Access to medicines and the European Intellectual Property (IP) protection environment (Public policy or programme) 4 On lobbying.ie
Sep–Dec 2019 Abbvie Limited Health Invitation to attend AbbVie presentation (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2019 Abbvie Limited Health Presentation during IBEC regional meeting (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2019 Abbvie Limited Health Neurology policy in Ireland (Public policy or programme) 1 On lobbying.ie
Sep–Dec 2019 Abbvie Limited Health Access to medicines and the European Intellectual Property (IP) protection environment (Public policy or programme) 11 On lobbying.ie
Sep–Dec 2019 Abbvie Limited Health To invite representatives to attend AbbVie STEM events (Public policy or programme) 6 On lobbying.ie
Sep–Dec 2019 Abbvie Limited Health To discuss HCV elimination (Public policy or programme) 2 On lobbying.ie
Sep–Dec 2019 Abbvie Limited Health Discussion on Budget 2019 (Matters involving public funds) 1 On lobbying.ie
Sep–Dec 2019 Abbvie Limited Health Briefing note on access to medicines (Public policy or programme) 4 On lobbying.ie
Sep–Dec 2019 Abbvie Limited Health Meetings to discuss access to medicines (Public policy or programme) 2 On lobbying.ie
May–Aug 2019 Abbvie Limited Health Parkinsons Disease funding in Ireland and medicines reimbursement (Public policy or programme) 6 On lobbying.ie
May–Aug 2019 Abbvie Limited Health To discuss access to medicines and the European Intellectual Property protection environment (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Abbvie Limited Health To invite Minister to STEM launch event (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Abbvie Limited Health To discuss access to medicines and pharmacy-led substitution (Public policy or programme) 1 On lobbying.ie
May–Aug 2019 Abbvie Limited Health To invite representatives to attend AbbVie corporate responsibility event (Public policy or programme) 9 On lobbying.ie
May–Aug 2019 Abbvie Limited Health To discuss HCV elimination (Public policy or programme) 5 On lobbying.ie
May–Aug 2019 Abbvie Limited Health To discuss access to oncology medicines, HCV elimination and non-medical switching (Public policy or programme) 10 On lobbying.ie
Jan–Apr 2019 Abbvie Limited Health To invite Minister to STEM event launch (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2019 Abbvie Limited Health To discuss access to oncology medicines, HCV elimination and non-medical switching (Public policy or programme) 2 On lobbying.ie
Jan–Apr 2019 Abbvie Limited Health To discuss proposed changes to legislation regarding Supplementary Protection Certificates (Legislation) 5 On lobbying.ie
Jan–Apr 2019 Abbvie Limited Health To discuss Ireland's medical supply chain (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2019 Abbvie Limited Health To discuss Ireland's HCV elimination policy (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Abbvie Limited Health Provided Industry briefing on delay in access to new medicines in Ireland (Public policy or programme) 1 On lobbying.ie
May–Aug 2018 Abbvie Limited Economic Development and Industry To present the EY-DKM report on the importance of a robust IP framework to the Pharmaceutical Industry along with the Trade Associations submission to the public consultation on the EU SPC Waiver proposal (Legislation) 1 On lobbying.ie
May–Aug 2018 Abbvie Limited Health To highlight delays in access to an innovative new medicine for Chronic Lymphocytic Leukaemia for patients in Ireland that is available in other European countries (Public policy or programme) 1 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 50 84.7%
Economic Development and Industry 5 8.5%
EU Affairs 1 1.7%
Energy and Natural Resources 1 1.7%
Environment 1 1.7%
Taxation 1 1.7%